0001104659-15-057798.txt : 20150807 0001104659-15-057798.hdr.sgml : 20150807 20150807174729 ACCESSION NUMBER: 0001104659-15-057798 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150728 FILED AS OF DATE: 20150807 DATE AS OF CHANGE: 20150807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mylan N.V. CENTRAL INDEX KEY: 0001623613 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981189497 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL BUSINESS PHONE: 44 0 1707 853 000 MAIL ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL FORMER COMPANY: FORMER CONFORMED NAME: New Moon B.V. DATE OF NAME CHANGE: 20141028 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abbott Products CENTRAL INDEX KEY: 0001650190 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 333-199861 FILM NUMBER: 151038693 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064 BUSINESS PHONE: 224-668-3591 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064 3 1 a3.xml 3 X0206 3 2015-07-28 0 0001623613 Mylan N.V. MYL 0001650190 Abbott Products 70, SIR JOHN ROGERSON'S QUAY DUBLIN L2 IRELAND 0 0 1 0 Ordinary Shares, nominal value EUR0.01 per share 62782018 D The Ordinary Shares of Mylan N.V. ("Mylan") described in this report are held directly by Abbott Products ("Abbott Products"). Abbott Laboratories ("Abbott") previously reported beneficial ownership of the Ordinary Shares described in this report and certain other Ordinary Shares of Mylan owned by Abbott Investments Luxembourg S.a r.l ("Abbott Luxembourg" and together with Abbott Products, the "Subsidiaries"), on a report on Form 3 filed with the Securities and Exchange Commission (the "SEC") on March 6, 2015. Each of the Subsidiaries is an indirect, wholly-owned subsidiary of Abbott. In Abbott's capacity as the ultimate corporate parent of the Subsidiaries, Abbott may be deemed to indirectly beneficially own such Ordinary Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC thereunder. Exhibit List: Exhibit 24.1 - Power of Attorney ABBOTT PRODUCTS Thomas C. Freyman 2015-08-07 EX-24.1 2 ex-24d1.htm EX-24.1

Exhibit 24.1

POWER OF ATTORNEY

ABBOTT PRODUCTS

Know all men by these presents that Abbott Products does hereby make, constitute and appoint Hubert L. Allen, John A. Berry and Jessica H. Paik, or any one of them, as a true and lawful attorney-in-fact of the undersigned with full powers of substitution and revocation, for and in the name, place and stead of the undersigned (both in the undersigned’s individual capacity and as a manager or member of any limited liability company, as a partner of any partnership, as an officer of any corporate or other entity, or in the undersigned’s capacity in a position similar to the foregoing at any entity, in each case, for which the undersigned is otherwise authorized to sign), to execute and deliver such forms, schedules, statements and other documents as may be required to be filed from time to time with the Securities and Exchange Commission with respect to (i) Sections 13(d), 13(g), 13(f), 13(h) and 16(a) of the Securities Exchange Act of 1934, as amended, including Schedule 13D, Schedule 13G, Form 13F, Form 13H, Form 3, Form 4 and Form 5 and (ii) in connection with any applications for EDGAR access codes, including Form ID.

	/s/ AJ Shoultz
	Name: AJ Shoultz, Director

Date: July 31, 2015